The European Cancer Congress (ECC2015) is undoubtedly the largest European platform for presenting ground-breaking data to a global audience.
We are on a path where each Congress sets new records – ECC2011 in Stockholm and ECC2013 in Amsterdam both attracted record numbers of participants and submitted abstracts. ECC2013 in Amsterdam registered 16% growth in delegates and a massive 38% increase in the number of submitted abstracts compared to our event in Stockholm.
Our late-breaking submission policy is specially designed to ensure the Congress embraces all promising new developments to ensure a very advanced, forward-looking scientific programme. Topics of the greatest interest to a multidisciplinary audience are presented by the very experts who work on them.
The European Cancer Congress is now giving fresh impetus to its unique philosophy of collaborative innovation to improve outcomes and find new solutions to pressing issues. We have designed more integrated sessions bringing about dialogue and debate in overlapping areas of scientific research. The programme is therefore more streamlined, with fewer tracks, facilitating an even more productive experience for delegates.
The European Cancer Congress remains the only European cancer meeting with a dedicated Oncopolicy track. The Oncopolicy Forum in Amsterdam tackled topics including research, personalised medicine and care, organisation of specialised care, and translation of evidence into policy. The recommendations derived from these discussions will be revisited at the Oncopolicy Forum in Vienna in 2015.
Our Patient Advocacy Track will carry forward its work in highlighting key issues for patients and survivors and exploring partnerships with all stakeholders in the oncology community.
ECC2015 will again be the largest CME ACOE accredited event in Europe. In addition, we have enriched the programme with new elements over and above those of CME – we envisage unique mentorship opportunities and various other ways of enhancing knowledge and skills beyond the scientific programme.
There is a single aim behind all these efforts – to make the European Cancer Congress the most powerful of platforms for improving cancer care, outcomes and quality of life for all people with cancer.
This vision brought us to Vienna – a vibrant city and such a natural host of ECC2015. Vienna’s track record as a leader in medical thought and practice speaks for itself – its historic contribution has made its mark in key areas like radiotherapy, clinical diagnosis and public health to name a few.
We look forward to welcoming you to Vienna!
Martine Piccart, Congress Chair, ECCO President
Rolf A. Stahel, ESMO President
Peter Naredi, Scientific Co-Chair
Elisabeth De Vries, Scientific Co-Chair
Christoph Zielinski, National Organising Committee Chair
PRINT THIS PAGE